Federal Register #A-570-234

Antidumping and Countervailing Duty Investigations of CBS Imports from China

The U.S. Department of Commerce, International Trade Administration, has launched antidumping (AD) and countervailing duty (CVD) investigations into imports of N-Cyclohexylbenzothiazole-2-Sulfenamide (CBS) from China. - Government Buyer: - U.S. Department of Commerce, International Trade Administration, Enforcement and Compliance Office - Product of Interest: - N-Cyclohexylbenzothiazole-2-Sulfenamide (CBS), also known as Accelerator CZ, CBTS, Thiohexam, HIP4, Curax, DURAX, Conaca, Conach, Conacs, or Celacs - Chemical formula: C13H16N2S2; CAS registry No. 95330; concentration 94-99% - Typically supplied as off-white or light gray powder, oiled powder, or granules - OEMs and Vendors: - No specific OEMs or vendors are named in the investigation - LANXESS Corporation is identified as the domestic petitioner - Multiple Chinese producers/exporters will be identified for respondent selection - Products/Services Requested: - Collection of pricing, production, and export data for CBS imports from China - Submission of comments and factual information regarding CBS's scope, physical characteristics, and industry support - Unique or Notable Requirements: - Respondents must file electronically via the ACCESS system - Exporters and producers must submit separate rate applications - Compliance with certification and procedural guidelines is required - The investigation covers both less-than-fair-value sales and countervailable subsidies - Period of Investigation: - AD: October 1, 2025 – March 31, 2026 - CVD: January 1, 2025 – December 31, 2025 - Place of Performance/Delivery: - U.S. Department of Commerce Headquarters, 1401 Constitution Avenue NW, Washington, DC 20230

Description

The Department of Commerce, International Trade Administration, has initiated a less-than-fair-value (LTFV) investigation into imports of N-Cyclohexylbenzothiazole-2-Sulfenamide (CBS) from the People's Republic of China. The investigation aims to determine whether CBS is being sold in the United States at less than fair value, which may involve examining pricing, production, and export data. Interested parties are invited to submit comments and factual information relevant to the scope of the investigation by specified deadlines. The investigation will follow statutory and regulatory time limits, with preliminary determinations expected within 140 days of initiation.

View original listing